The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
Danny Ulahannan, Adrian WaggDepartment of Geriatric Medicine, University College Hospital, London, UKAbstract: After lifestyle and behavioral measures to control overactive bladder, the mainstay of pharmacological treatment is the use of antimuscarinic therapy. Overactive bladder predominantly affec...
Guardado en:
Autores principales: | Danny Ulahannan, Adrian Wagg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7ecdbb11e6b34920961bfaa4c66f2845 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient
por: Makhani A, et al.
Publicado: (2020) -
Acupuncture for Treatment of Overactive Bladder
por: Maryam Hosseini, et al.
Publicado: (2021) -
Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin
por: Bilal Chughtai, et al.
Publicado: (2008) -
Overactive bladder: strategies to ensure treatment compliance and adherence
por: Dhaliwal P, et al.
Publicado: (2016) -
Evaluation of Silodosin and Pelvic Floor Muscle Training in Men with Benign Prostatic Hyperplasia and Overactive Bladder (Silodosing) Study Protocol (Spirit Compliant)
por: Magdalena Hagovska, et al.
Publicado: (2021)